Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to Extraordinary General Meeting 2022

The shareholders in RaySearch Laboratories AB (publ), corporate identity no. 556322-6157, are hereby invited to the Extraordinary General Meeting, to be held on Wednesday, November 9, 2022.The Board of Directors has decided that the General Meeting is to be held only through postal voting in accordance with temporary legislation applicable since March 1, 2022. This means that the General Meeting will be conducted without the physical presence of shareholders, representatives or external parties. Shareholders will only be able to exercise their voting rights by postal voting in advance of

ChromoGenics presents at Redeye Theme: Property Technology 2022

ChromoGenics will be participating at Redeye Theme: Property Technology on the 14[th] of October.On October 14 at 10:50 CET, CEO, Fredrik Fränding, will present the latest developments in the company at Redeye. The presentation is live broadcasted and can be followed at https://www.redeye.se/events/847051/redeye-theme-property-technology at where the replay and the presentations will be available afterwards.

Customer experience gaining importance as a success factor

An increasing number of players are competing for customers’ attention. "The customer experience is therefore becoming a key factor to success in the financial sector." This is the message from Handelsbanken’s digitalisation expert, Malin Lignell, in the Journal of Digital Banking.Competition for people’s attention is not only about being able to offer the best experience among competitors within the same sector, but also between different industries.  People are more likely to prioritise their time with the player that can provide the best customer experience and offering. In this in-

Katarina Levin resigns as CEO of Setra

Setra's CEO Katarina Levin leaves her position at Setra's Annual General Meeting in May 2023."After careful consideration, I have decided to leave my role as CEO. It is all due to personal reasons, I simply wish to manage my time more freely. The board has been notified of my decision and I intend to fulfill the CEO assignment until May 2023", says Katarina Levin.Katarina Levin assumed her position on January 1, 2020. It has been a time marked by the covid pandemic and an extreme increase in demand during 2021 and the beginning of 2022."With Katarina, Setra has had a fantastically

Advenica receives order worth MSEK 1.4 for cybersecurity products from a customer in the public sector

Advenica has received a new order for cybersecurity products with high assurance from a Swedish customer in the public sector.If you need to transfer data to or from a protected network, a good way to ensure that the transfer is carried out securely is to use a data diode. A data diode is a cybersecurity solution that ensures a one-way flow of information. This hardware product, with its high assurance, maintains both network integrity by preventing intrusions and network confidentiality by protecting the most sensitive information. Advenica has now received a new order from a Swedish

NextCell publishes opinion piece with ISCT

NextCell Pharma AB (”NextCell” or ”Company”) published an opinion piece on particulates in cell and gene therapy products with the International Society for Cell and Gene Therapy’s Process Development, Manufacturing and Analytics Committee last week in the journal Cytotherapy.NextCell Pharma AB is a cell therapy company working in the development and commercialization of the mesenchymal stromal cell therapy product, ProTrans. This product, with its proprietary platform technology, is in clinical development for the treatment of autoimmune conditions, such as type I diabetes and inflammatory

Össur hf: Q3 2022 Results - Conference Call Tuesday 25 October at 9:00 CEST

Announcement no. 58/2022 11 October 2022 Conference call on Tuesday 25 October at 9:00 CEST / 7:00 GMT / 3:00 ET Össur will publish its financial results for Q3 2022 prior to market opening on Tuesday 25 October. That same day at 9:00 CEST, Össur will host a conference call where Sveinn Sölvason, President and CEO, and Gudný Arna Sveinsdóttir, CFO, will present and discuss the results of the quarter. The conference call will be conducted in English. A webcast can be followed on the Össur website: http://www.ossur.com/investors To participate in the conference call, please

Aker Solutions ASA: Invitation to Presentation of Third-Quarter Results for 2022

October 11, 2022 - Aker Solutions will publish its third-quarter results for 2022 on Tuesday, October 25, at 07:00 CEST. A live audiocast will take place the same day at 09:00 CEST.The results will be presented by audiocast. To join the live audiocast, go to https://www.akersolutions.com/audiocast There will be a Q&A session at the end of the presentation. Written questions can be submitted through the audiocast solution or sent in advance totorbjorn.andersen@akersolutions.com After the live presentation there will be an opportunity for the press to do individual interviews.

Integrum is granted patent approval for its OPRA[TM] Implant System from the US Patent and Trade Organization

Mölndal, Sweden, October 11[th], 2022 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces today that the company has received a patent approval in the US describing components and design features of the OPRA[TM] Implant System, including elements that were implemented in 2017 and later were granted a PMA approval in late 2020. The patent period extends until 2044.Integrum develops the OPRA[TM ]Implant System, a revolutionary implant technology based on the company’s deep expertise and innovations in osseointegration, that help amputees regain normal mobility and quality

BGaming Celebrates Spooky Season in New Halloween Bonanza

Featuring reels packed with Halloween attributes and symbols, the action takes place on a 6×5 layout, utilising cascading reels to land consecutive wins.The studio is all set for the Halloween celebrations and welcomes players to engage with its spookiest release of the year, Halloween Bonanza . Featuring reels packed with Halloween attributes and symbols, the action takes place on a 6×5 layout, utilising cascading reels to land consecutive wins.  Landing 4+ burning pumpkin scatter symbols unlocks the Free Spins bonus round, awarding a

Gedea Biotech reports results from placebo-controlled clinical trial of pHyph, an antibiotic-free treatment for bacterial vaginosis

· Symptom reduction was seen in 90% of patients and absence of symptoms was noted in 70% of patients · Clinical cure rate was 50,4% in the pHyph group, which is in line with many antibiotic treatments on the market · The rate of recurrence of BV was substantially lower at day 35 with pHyph, 13.9%, compared to the standard treatment, 47.5% and throughout the 4 monthsLund, Sweden, October 11, 2022. Gedea Biotech, an innovative women’s health company today reported top-line results from a clinical study, NEFERTITI, of its lead product, pHyph, a vaginal tablet for topical treatment of

Invitation to AAK’s presentation of the third quarter on October 25

In connection with the release of AAK’s Interim report for the third quarter 2022, we invite you to a press and analyst conference to be held on Tuesday, October 25, 2022, at 10 a.m. CET.The conference will be chaired by Johan Westman, President and CEO, and Tomas Bergendahl, CFO.The presentation will be held in English. The presentation can be followed by phone or via a webcast. Please note that questions may be asked by phone only.   To follow the conference by phone, please use one of the numbers below, followed by pin code 2174196.   SE: +46 8 505 163 86 UK: +44 20

Kindred Group’s Q3 report 2022 and invitation to conference call

Kindred Group plc will publish its interim report for the third quarter 2022 on Thursday 27 October 2022 at 07.30 (CEST).In connection with this, Kindred Group’s CEO Henrik Tjärnström will host a web presentation in English at 10.00 (CEST) which is webcasted live on https://www.kindredgroup.com/q32022. To access the telephone conference in connection with the presentation, please register at https://conference.financialhearings.com/teleconference/?id=10010042. After registration you will be provided phone numbers and a conference ID to access the conference. Please call in well in

Repurchase of NCC Series B shares in week 40, 2022

During the period October 3 – October 7, 2022, NCC (LEI-code 213800WRGLW3CY4MHW53) repurchased a total of 537,310 own Series B shares (ISIN: SE0000117970) under the framework of the repurchase program that the Board have decided.The repurchases are part of the repurchase program of a maximum of 10 percent of Series B shares for a total of not more than SEK 1.5 bn that NCC announced on April 27, 2022. The repurchase program extends from May 11, 2022 until the 2023 Annual General Meeting and is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the

Invitation to SSAB’s third quarter 2022 results briefing

SSAB invites you to a presentation of the report for the third quarter of 2022 at 9.30am CEST on Tuesday, October 25, 2022. The report will be published at approximately 7.30am CEST on the same date.The report will be presented by SSAB’s President and CEO Martin Lindqvist, and CFO Leena Craelius. The press conference will be held in English and live webcast on SSAB’s website www.ssab.com. You can also participate in the briefing by telephone. Venue and time of briefing: World Trade Center (WTC) Stockholm, Kungsbron 1, Conference room Manhattan, 9.30am CEST. Teleconference numbers:

Significant Commercial Order received for Zwipe Pay Platform

OSLO, NORWAY– 11 October 2022 – Zwipe is proud to announce a significant commercial order for its Zwipe Pay platform, which enables smart card manufacturers to deliver biometric payment cards. This order has been placed by one of the world’s largest smart card manufacturers delivering tens of millions of payment cards globally. The order value is approximately USD 225,000 and the shipment is targeted for later Q4 2022, making it the single largest commercial order for a quarter in Zwipe’s history. Most notably this initial order is part of a larger volume that the smart card manufacturer

Bridging big to small dimensions: The new COOL-FIT 2.0 Push System

COOL-FIT 2.0 from GF Piping Systems has already changed how you plan, install and operate cooling applications. The pre-insulated plastic piping system is corrosion- and condensation-free and can be installed in cooling applications in commercial and residential construction, data centers, or process cooling. Thanks to the COOL-FIT 2.0 Push System, it now becomes a complete solution: Additional dimensions cover the last meter between the main pipeline and the HVAC unit, leading to higher energy efficiency and a more reliable operation.HVAC technology is becoming increasingly important. The

INVITATION TO PRESENTATION OF MUNTERS INTERIM REPORT JANUARY-SEPTEMBER 2022

On October 21, at 07.30 CET, Munters will release the interim report for January-September for 2022. Media, investors and analysts are on the same day invited to attend a presentation of the report at 09.00 CET. The President and CEO, Klas Forsström, together with the Group Vice President and CFO, Annette Kumlien will present the report in a webcast with telephone conference. Webcast: Link to webcast: https://ir.financialhearings.com/munters-q3-2022 Conference call: Please, dial in using one of the numbers below and the pin code: SE: +46 8 505 163 86UK: +44 20 319 84884

Eltel’s Nomination Committee composition for the AGM 2023

Pursuant to the instruction for Eltel AB´s Nomination Committee the company shall have a Nomination Committee comprising one representative for each of the four largest shareholders, registered with Euroclear Sweden AB on the last banking day in August the year before the Annual General Meeting (AGM).On 31 August 2022, the four largest shareholders of Eltel AB were Solero Luxco S.á.r.l. (a company controlled by Triton Funds), Wipunen Varainhallinta Oy, the Fourth Swedish National Pension Fund (AP4), and Heikintorppa Oy. All of the shareholders referred to above together represent 48.2% of

Inwido AB’s Nomination Committee for the 2023 Annual General Meeting

Based on the ownership structure as of August 31, 2022 the largest shareholders in Inwido AB (publ) in terms of voting rights were consulted and expressed their desire to participate in the nomination process. The Nomination Committee has been appointed by Swedbank Robur Fund, the fourth AP Fund and the Lannebo Fund. Each has appointed a representative, as detailed below, who, together with Per Bertland, the chairman of the board, constitute Inwido´s Nomination Committee.Members of the Nomination Committee: · Bo Lundgren, Swedbank Robur Fund (Chairman of the Nomination Committee) ·

Invitation – SEB’s results for the third quarter 2022

On Wednesday 26 October, at approximately 07:00 CET, SEB’s results for the third quarter 2022 will be announced. In addition, presentations and the Fact Book will be available at sebgroup.com/ir . You are invited to participate in the following event: Telephone conferenceTime: 09:00 CETJohan Torgeby, SEB’s President and CEO, and Masih Yazdi, CFO, will present the results, followed by a Q&A session with Johan Torgeby, Masih Yazdi and Pawel Wyszynski, Head of Investor Relations. The presentation and Q&A will be conducted in English. To participate in the

IFS announces winners of the 2022 Partner of the Year Awards

Miami, Florida, UNITED STATES, October 11, 2022 – IFS, the global cloud enterprise software company, is today announcing the winners of its Partner of the Year Awards. The annual event recognizes partners’ continued dedication to the IFS Partner Program, commitment to excellence in the service(s) delivered to mutual customers, and expertise in leveraging innovation to extend the capabilities of IFS’s solution. The announcement is taking place this year at the IFS global partner event, IFS Unleashed (Miami Beach Convention Center (MBCC), Miami, Florida, United States, October 10-14, 2022).

BioStock: Chordate introduces migraine treatment in Finland

Chordate Medical recently presented positive results from the German part of a large migraine study showing that K.O.S is an effective and safe treatment for chronic migraine. With these study results, the company chooses to broaden its focus on chronic migraine and introduce the treatment in Finland, as the successful PM007 study also includes Finnish clinics. The company’s CEO Anders Weilandt tells us more in an interview with BioStock.Read the full article at biostock.se: https://www.biostock.se/en/2022/10/chordate-introduces-migraine-treatment-in-finland/ This is a press release

Eficode becomes an official Atlassian Specialized Partner in ITSM

Productized ITSM services enable tighter collaboration between IT operations and software developmentHelsinki, Finland, October 11, 2022 – Eficode  is at the forefront in the Nordics to become an official Atlassian Specialized Partner in ITSM. The ITSM specialization demonstrates Eficode’s deep knowledge, extensive experience, and delivery of consistent, high-quality services to optimize customer satisfaction and outcomes. “Atlassian would like to recognize Eficode for their specialized delivery practice, as they have proven success implementing service

Read original
There are no items matching the current filter
There are no more items matching the current filter
Back to top